Tag archive for ‘Galmed Pharmaceuticals’
Jewish Business News On Thursday, December 10th, 2015

Drug for fatty liver disease in advanced studies

  Non-alcoholic fatty liver disease is reportedly the most common liver condition in the developed world, affecting about 30 percent of that population. The only cure is dietary modifications and exercise, More...

Liver Disease Biotech Galmed Files For A $35 Million IPO

– Galmed Pharmaceuticals Ltd., a clinical-stage biotech developing therapies for liver diseases and gallstones, filed on Thursday with the SEC to raise up to $35 million in an initial public offering, More...

Wordpress site Developed by Fixing WordPress Problems